Investor relations / Governance

Board oversight.
Independent accountability.

BioNexus maintains a majority-independent Board supported by standing committees with defined oversight responsibilities.

Experience aligned with public-company oversight.

The Board oversees BioNexus's strategy, financial reporting, risk management and compliance. Three independent directors provide oversight through the Audit, Nominating and Corporate Governance, and Compensation Committees.

Board and committee information below reflects the company's 2025 Form 10-K, filed April 14, 2026. Subsequent SEC filings should be consulted for any later changes.

Read the 2025 Form 10-K (opens in a new tab)
4Directors
3Independent directors
3Standing committees

Leadership, operating and oversight experience.

The Board combines executive leadership with independent experience in finance, audit, law, intellectual property and corporate governance.

Su-Leng Tan Lee

Chief Executive Officer, President & Director

Executive director

Mr. Tan Lee has more than two decades of management experience spanning life sciences, investment management, property, hospitality and government liaison. He joined BioNexus as Chief Operating Officer in 2023, became Chief Executive Officer in December 2023 and was appointed President in November 2024.

His earlier roles include Chief Commercial Officer of Dryox Health, owner and Managing Director of FLO Life Sciences Group, and President of Avillion Berhad. His work has centred on commercialization, finance and general management.

Muhammad Azrul bin Abdul Hamid

Independent Director

Compensation ChairNominating ChairAudit member

Mr. Azrul has more than two decades of legal experience, including intellectual-property, contract, debt-recovery and tort matters before the Malaysian High Court and Court of Appeal. He has also advised technology businesses on intellectual-property protection, public policy and government engagement.

His professional service has included the Malaysian Eurocham IP Committee, Kuala Lumpur Bar Committee IT Committee and Bar Council Cyberlaw Committee, alongside regional intellectual-property education and speaking engagements.

Chee Keong Yap

Independent Director

Audit ChairFinancial expertCompensation member

Mr. Yap is a member of the Institute of Chartered Accountants of Scotland with extensive experience in auditing, merchant banking, corporate finance and public-company leadership. He has served on the BioNexus Board since March 2022.

His previous roles include Managing Director and Executive Director of Niche Capital Emas Holdings Berhad and Chief Executive Officer and Executive Director of Bumiputra Merchant Bankers Berhad. The Board has designated him as its Audit Committee Financial Expert.

Jook Yuen Low

Independent Director

Audit memberNominating member

Ms. Low is a Malaysian lawyer with more than two decades of experience across conveyancing, corporate law and wealth-management consulting. She joined the BioNexus Board in November 2024 and is a partner of Azura Mokhtar & Low.

Her practice includes property, real-estate and banking transactions, as well as corporate agreements involving shareholders, joint ventures and powers of attorney. She holds an LLB and a Master of Business in Public Relations from Queensland University of Technology.

Defined mandates. Independent review.

Each standing committee operates under a written charter and is composed solely of independent directors.

01

Audit Committee

Chee Keong Yap, ChairMuhammad Azrul bin Abdul Hamid · Jook Yuen Low

Oversees financial reporting, the independent auditor, internal controls and related compliance and risk matters. All members are independent, and Chee Keong Yap is the committee’s financial expert.

Audit Committee Charter (opens in a new tab)
02

Nominating & Corporate Governance Committee

Muhammad Azrul bin Abdul Hamid, ChairJook Yuen Low

Evaluates director candidates, Board composition and corporate-governance practices, and makes recommendations to the Board within its chartered mandate.

Nominating Committee Charter (opens in a new tab)
03

Compensation Committee

Muhammad Azrul bin Abdul Hamid, ChairChee Keong Yap

Provides independent remuneration oversight, including executive compensation, incentive arrangements and the alignment of compensation practices with shareholder interests.

Compensation Committee Charter (opens in a new tab)

Policies and primary-source disclosures.

These filed materials set out the standards and responsibilities that support Board and company conduct.

Shareholder meeting materials

Proxy statements describe the matters put to shareholders, director nominees and voting procedures. Results of shareholder votes are reported on Form 8-K. This list updates automatically from SEC EDGAR.